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1. Introduction 
Hormonal and nutritional regulation of lipoprotein 
lipase (LPL) activity of heart has been studied in the 
intact animal [ 1,2] and in isolated heart cells main- 
tained in tissue culture [3]. Recently, cellular LPL 
activity was shown to decrease when the culture 
medium had been supplemented with 0.07 mg/ml of 
very low density lipoproteins (VLDL) triacylglycerol 
for 3 h [4]. Since the highest levels of enzyme activity 
were seen in cells grown in a medium with a very low 
triacylglycerol content, it seemed of interest to deter- 
mine if elimination of plasma VLDL in the intact rat 
will result in an increase of heart LPL. This can be 
easily achieved by injection of 4-aminopyrazolo- 
[3,4-dlpyrimidine (4-APP), which has been shown 
to reduce markedly plasma lipoprotein levels [.5]. The 
results of the present experiments were expected to 
elucidate the possible role of the substrate in the 
regulation of heart LPL activity in vivo. 
2. Materials and methods 
Male albino rats (200 g body wt) of the Hebrew 
University strain, kept in temperature- and light-con- 
trolled rooms were used. The rats had free access to 
food until 12:00 h, when they were injected intra- 
peritoneally with 4-APP (50 mg/kg), in 10 mM phos- 
phate buffer (pH 3 .O) [6] or with buffer alone. There- 
after the rats were kept in wire-bottom cages and had 
access to water only. VLDL was isolated from plasma 
of sucrose-fed rats as in [7]. Chylomicrons were 
obtained from chylous pleural effusion and isolated 
and washed twice by centrifugation at 15°C for 
30 min at 10 000 rev./min. Lipoprotein lipase activity 
of heart [8] and triglyceride h+drolase activity of 
liver [9 ] was determined on fresh tissue homogenates 
and enzyme activity of epididymal fat pads was car- 
ried out on acetone powders as in [lo]. Serum triacyl- 
glycerol (TG) was determined as in [ 111. In 4-APP 
injected rats 2.0 ml serum had been lyophilized and 
redissolved in 0.5 ml water prior to TG determination. 
Serum insulin was determined by a modified radio- 
immunoassay [ 121, and serum 11 -hydroxycorticoids 
were determined by a fluorimetric method [ 131. 
4-APP was obtained from Aldrich Chem. Co., 
Milwaukee, WI. 
3. Results 
To study the relation between plasma TG level and 
LPL activity of heart, rats were treated with 4-APP 
and the enzyme activity was compared to that of 
control rats. As seen in table 1,4-APP treatment for 
22 h resulted in a marked fall in plasma TG level and 
a rise in the LPL activity of heart. A similar increase 
in heart LPL activity occurred also in non-fasted, 
4-APP treated rats (data not shown). The 20-22 h 
interval after 4-APP treatment was used in all experi- 
ments, since no change in heart LPL activity was 
observed after 3 h and 6 h treatment. In order to 
determine whether the 4-APP effect on heart LPL 
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Table 1 
Effect of VLDL and chylomicrons on lipoprotein lipase activity of heart in 
4-APP-treated rats 
Treatment Lipoprotein lipase act. 
fatty acid released 
(pmol/g wet wt/h) 
Plasma 
Glucose TG 
(mg/dl) 
Control 98.2~ 1.9 (18) 101 39 
4-APP 170.8? 1.7 (20) 99 8 
4-APP + VLDL (5 mg/h) 102.5 t 1.8 (3) _ 35 
4-APP + VLDL (15 mg) 103.3 + 1.2 (12) 101 19 
4-APP + chylomicrons (20 mg) 120.6 f 1.3 (4) 97 8 
I-APP + chylomicrons (2 x 20 mg) 119.3 + 0.8 (3) 103 13 
4-Aminopyrazolopyrimidine (4-APP), 50 mg/kg, was injected intraperitoneally. 
The rats were deprived of food and were kept individually in wire bottom cages. 
VLDL or chylomicrons were irtjected i.v. 19 h after 4-APP and all rats were killed 
22 h after 4-APP. VLDL was either infused for 3 h at 5 mg triacylglycerol/h, or 
injected as a single dose. Chylomicrons were given as 1 or 2 injections, 90 min 
apart. Values are means + SE or means. Numbers in parentheses represent no. rats 
can be modulated by plasma VLDL or chylomicrons, 
various amounts of these lipoproteins were injected 
or infused and enzyme activity was determined 3 h 
thereafter. Injection of 15 mg VLDL-TG given as 
a single bolus or infused for 3 h at 5 mg/h resulted 
in a decrease in heart LPL activity to almost control 
values (table 1). Injection of chylomicrons resulted 
also in a decrease in heart LPL activity, but the 
effect was less pronounced. This could have been 
due to the more rapid clearance of chylomicrons from 
the circulation. An attempt was made to obtain a 
more sustained elevation in plasma TG level by intra- 
gastric administration of oil. However, only a small 
reduction in heart LPL activity occurred 3 h after 
oil feeding, probably due to impaired intestinal 
absorption of fat [ 141. 
Plasma levels of glucose were determined in all 
groups of animals and ranged between 97-103 mg/dl. 
Serum insulin and 11 -hydroxycorticoid levels after 
4-APP treatment were not different from control 
values. The comparison of the effect of 4-APP treat- 
ment on LPL in the heart and adipose tissue and on 
hepatic TG hydrolase activities is presented in table 2. 
At the time when LPL activity in the heart increased 
by 70%, the enzyme activity in adipose tissue 
decreased by 60%, and the hepatic TG hydrolase by 
40% (table 2). 
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4. Discussion 
Lipoprotein lipase activity in the intact rat has been 
usually correlated with plasma levels of glucose, 
insulin or corticosteroid hormones [ 1,2]. In studies 
with cultured heart cells, addition of VLDL to the 
medium resulted in a fall in LPL activity which was 
very pronounced after 3 h incubation [4]. This fall 
suggested that a product of interaction between 
Table 2 
Effect of 4-APP on lipoprotein lipase of heart and adipose 
tissue and triacylglyccrol hydrolase of liver 
Enzyme 
source 
Enzyme activity 
Control 4-APP 
Heart 97 i 5.1 (IZ = 5) 167 ? 4.1 (n = 5) 
Fat pad 165 + 11.5 (n= 7) 63 i 2.3 (n = 5) 
Liver 80 t 3.3 (n = 10) 50 * 1.3 (I2 = 10) 
Conditions as in table 1. All rats were deprived of food after 
the injection of 4-APP. Enzyme activity was determined on 
fresh homogenates of heart and liver and is expressed as fatty 
acid released, pmol/g wet wt/h. The enzyme activity of 
adipose tissue was determined on acetone powder and is 
expressed per g acetone powder. Values are means * SE. 
Numbers in parentheses represent no. rats 
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VLDLand LPLdepresses the synthesis of the enzyme. 
The present experiments were designed to test whether 
extreme reduction of plasma TG level will stimulate 
heart LPL activity. Such a reduction of plasma TG 
level in fasted rats was achieved by treatment with 
4-APP which affects hepatic release of secretory pro- 
teins (51 and 1ecithin:cholesterol acyltransferase [15 1, 
without depressing total hepatic protein synthesis [5]. 
The increase of LPL activity 20-22 h after 4-APP 
was encountered only in the heart, while enzyme 
activity decreased in adipose tissue and liver. This 
fall in the LPL activity of adipose tissue and in TG 
l~ydrolase of liver could explain the reported reduc- 
tion in lipolytic activity of postheparin plasma in 
4-APP-treated rats [ 161. In the 4-APP-treated rat 
when plasma TG was barely measurable, there was 
no change in plasma glucose, insulin and 1 l-hydro- 
corticoid levels and no change in plasma free fatty 
acid levels had been reported [ I6J. 
These findings of a rise in heart LPL activity 
concomitant with a marked reduction of plasma 
TG and the reversibility of this increase by injec- 
tion of VLDL suggests that the heart enzyme might 
be regulated by its substrate, i.e., plasma triacyl- 
glycerol. 
In the fasted rat of 200 g body wt, the rate of 
VLDL release by the liver has been estimated to 
range between lo-20 mg TG/h (171. Thus the 
amount of VLDL injected presently into the 4-APP- 
treated rats was equivalent to -SO-Z% of the 
hepatic release of VLDL in the non-treated rat, 
indicating that even the low values observed in the 
fasted state are sufficient to keep the heart LPL 
activity at the physiological low values. 
The rate of clearance of plasma TG by the heart 
is determined largely by the concentration of the 
enzyme at the endothelial surface ofheart capillaries 
and is maximal even at low triglyceride concentra- 
tion, owing to its low Michaelis-Menton constant 
(K, value) of 0.07 mM TG [ 181. In the 4-APP 
treated rats, the plasma TG concentration was near 
the app. K, value. Thus it seems that since the 
heart is largely dependent on availability of free 
fatty acids for energy production, the extreme fall 
in plasma TG provides a signal for new enzyme 
synthesis. 
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